medicalxpress - Novo Nordisk said Thursday it would take legal action against a US chain offering a copycat of the new pill version of its Wegovy weight-loss drug.
AI Summary: Novo Nordisk has vowed to take legal action after discovering that competitors – including Hims & Hers – plan to market a compounded, lower‐priced version of its new Wegovy weight‐loss pill. The company is mobilizing its legal team to protect its intellectual property amid fierce market competition.
Andrew Jacobs / nytimes - The organization’s latest guidance is a departure from the prevailing views of several other major medical organizations.
AI Summary: Multiple reports confirm that the American Society of Plastic Surgeons is advising that elective gender‐affirming procedures for minors be delayed until patients reach age 19. The recommendation diverges from other medical group views and aims to enhance patient safety by waiting until later adolescence for irreversible surgical interventions.

StackHealth RSS
StackHealth Time Machine
More StackHealth
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.